1/2

Export Ready

Cladribin injection

Name: Cladribin injection
SKU: 8483645
Availability: InStoreOnly

Sold by ayursatva pharma llp · Raigad, Maharashtra, India

Price

Price on request

In stock

Inclusive of all taxes

Minimum order: 1 Centimetre

Export Snapshot

MOQ

1 Centimetre

Lead time

On request

Packaging

Single-use vials

Shelf life / longevity

As per product specification

HS Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for ayursatva pharma llp.

Compliance & Certifications

Suitable for

Importers · Distributors · Wholesalers

Raigad Dispatch on request Verified seller

ayursatva pharma llp

Verified seller · Raigad, Maharashtra, India

Registered address: RAIGAD, India.

View profile All products

Established

Not shared

Employees

–

GST

27ACGFA6465R1ZM

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Not shared

Turnover

Incorporation Type

On request

Verified Seller

Product details

What are the specifications of this product?

Overview

Cladribine is used in the treatment of hairy cell leukemia.

Product Description

Cladribine is used in the treatment of hairy cell leukemia.

Description provided by ayursatva pharma llp.

Specifications

Concentration	Approximately 2 mg/mL (dependent on formulation)
Packaging	Single-use vials
Shelf Life	Typically 24 months from manufacturing
Compatibility	Compatible with sterile intravenous fluids
Storage Temperature	2°C to 8°C (Refrigerated)
Pharmacological Classification	Antineoplastic agent
Preservatives	Preservative-free formulation recommended
Administration Frequency	Typically administered over 5 to 7 days in cycles as per oncologist prescription

Use cases

Category	Pharmaceuticals > Oncology Drugs > Antineoplastic Agents > Purine Analogs
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	Single-use vials
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 Centimetre
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Cladribin injection. Answers compiled from verified sellers' commercial terms and platform data.

Q: Is Cladribine injection safe for use in all stages of hairy cell leukemia?

A: Cladribine injection is primarily indicated for patients diagnosed with hairy cell leukemia and is typically administered following a detailed evaluation by an oncologist. Its safety and efficacy depend on the disease stage and patient's overall health.

Q: What precautions must healthcare providers take when administering Cladribine injection?

A: Healthcare professionals must ensure proper sterile techniques during administration, monitor patient blood counts regularly due to potential immunosuppression, and manage side effects carefully throughout the treatment cycle.

Q: How is the dosage of Cladribine injection determined for hairy cell leukemia patients?

A: Dosage is individualized based on patient weight, kidney function, and overall health status, following established clinical guidelines to optimize efficacy while minimizing toxicity.

Q: Are there any storage requirements unique to Cladribine injection?

A: Yes, Cladribine injection must be stored refrigerated between 2°C and 8°C and protected from light to maintain its stability and effectiveness.

Q: Can Cladribine injection be used in combination with other chemotherapeutic agents?

A: While primarily used alone for hairy cell leukemia, Cladribine may be combined with other therapies as determined by medical oncologists based on patient-specific factors.

Question not answered? Ask sellers directly — typical response within 4 hours.